Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9415)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 30, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Meta-Analysis
ISSN
2308-3840
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xourgia E, Tzouganatou EM, Papazafeiropoulou A, Melidonis A. Anti-inflammatory properties of antidiabetic agents. World J Meta-Anal 2019; 7(4): 129-141 [DOI: 10.13105/wjma.v7.i4.129] |
|---|---|
| URL: | https://www.wjgnet.com/2308-3840/full/v7/i4/129.htm |
| Number | Citing Articles |
| 1 |
Nami Lee, Yu Jung Heo, Sung-E Choi, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim, Theresa Hautz. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/9944880
|
| 2 |
Alina Kuryłowicz, Krzysztof Koźniewski. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes. Molecules 2020; 25(9): 2224 doi: 10.3390/molecules25092224
|
| 3 |
Rodrigo Damián García, Joana Antonela Asensio, Diahann Jeanette Perdicaro, María de los Ángeles Peral. The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular
Diseases. Current Vascular Pharmacology 2022; 20(3): 244 doi: 10.2174/1570161120666220201160038
|
| 4 |
Milena Cojic, Aleksandra Klisic, Amina Sahmanovic, Nemanja Petrovic, Gordana Kocic. Cluster analysis of patient characteristics, treatment modalities, renal impairments, and inflammatory markers in diabetes mellitus. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56451-1
|